WordNet

the 3rd letter of the Roman alphabet (同)c
(music) the keynote of the scale of C major
a general-purpose programing language closely associated with the UNIX operating system
tending to or capable of propelling; "propellant fuel for submarines"; "the faster a jet plane goes the greater its propulsive efficiency"; "universities...the seats of propulsive thought" (同)propellent, propelling, propulsive
any substance that propels (同)propellent

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 成人における吸入器の使用 the use of inhaler devices in adults
2. 小児における吸入器の使用 the use of inhaler devices in children
3. 喘息の治療におけるクロモン（クロモグリク酸）の使用 the use of chromones cromoglycates in the treatment of asthma
4. COPDにおける抗コリン療法の役割 role of anticholinergic therapy in copd
5. 成人における吸入剤の到達 delivery of inhaled medication in adults

Meltzer EO, Bensch GW, Storms WW.
Allergy and asthma proceedings : the official journal of regional and state allergy societies.Allergy Asthma Proc.2014 May-Jun;35 Suppl 1:S11-9. doi: 10.2500/aap.2014.35.3756.
Intranasal corticosteroids (INSs) have been effectively used for >40 years for the treatment of seasonal allergic rhinitis (SAR) and perennial AR (PAR). Following the Montreal Protocol, the initial aerosol formulations using chlorofluorocarbon (CFC) propellants were phased out. For the past 20 ye
PMID 25582157

Therapeutic equivalence of triamcinolone acetonide hydrofluoroalkane and chlorofluorocarbon nasal inhalers in patients with seasonal allergic rhinitis.

Schenkel E1, Newman KB.
American journal of rhinology & allergy.Am J Rhinol Allergy.2013 Mar-Apr;27(2):109-12. doi: 10.2500/ajra.2013.27.3857.
BACKGROUND: Triamcinolone acetonide (TAA) has been reformulated as an hydrofluoroalkane (HFA) aerosol for intranasal use in patients with seasonal allergic rhinitis (SAR). This study compared the TAA HFA formulation with the previously available chlorofluorocarbon (CFC) nasal inhaler in a dose-rangi
PMID 23562198

Brambilla G1, Church T, Lewis D, Meakin B.
International journal of pharmaceutics.Int J Pharm.2011 Feb 28;405(1-2):9-15. doi: 10.1016/j.ijpharm.2010.11.037. Epub 2010 Dec 1.
The temperature of the drug cloud emitted from a pressurised metered dose inhaler (pMDI) may result in patient discomfort and inconsistent or non-existent dose delivery to the lungs. The effects of variations in formulation (drug, propellant, co-solvent content) and device hardware (metering volume,
PMID 21129465